# FDA Inspection 1326202 - Yangzhou Aurisco Pharmaceutical Co.,Ltd. - June 19, 2026

Source: https://www.keypedia.com/records/fda_inspections/yangzhou-aurisco-pharmaceutical-coltd/f1b39958-e251-471e-b499-e20f09e5c5ea
Source feed: FDA_Inspections

> FDA Inspection 1326202 for Yangzhou Aurisco Pharmaceutical Co.,Ltd. on June 19, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1326202
- Company Name: Yangzhou Aurisco Pharmaceutical Co.,Ltd.
- Inspection Date: 2026-06-19
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1219992 - 2023-08-11](https://www.keypedia.com/records/fda_inspections/yangzhou-aurisco-pharmaceutical-coltd/ae28eee0-1e2b-46ee-813d-dc5b8d8c121d)

Company: https://www.keypedia.com/companies/yangzhou-aurisco-pharmaceutical-coltd/0ea3dfec-2357-4631-9b23-a9c72c73098b

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8